Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The surge in GLP-1 prescriptions presents a significant growth opportunity for health systems, particularly those participating in the 340B Program
Acknowledgements Work in the authors laboratory has been supported by grants from the NIH (DK57539, DK58282, DK64819 and DK63608-Columbia Diabetes Research Center)
Thomas JR, Nelson JK, Thomas KT
This legislation, if passed, would require Medicare to cover obesity medications, which could open the door for broader insurance coverage
Evidence suggests that prolonged or excessive use of semaglutide medications, including Ozempic, can lead to gastroparesis and other significant side effects
US$ 20.63
US$ 23.49
US$ 28.94
US$ 23.39
